.svg){kind=small}
Sep-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Canna Clinicals has demonstrated a consistent performance in the New York market within the Tincture & Sublingual category. Over the summer months, the brand maintained a steady presence in the top 10, ranking 9th in June and August, and improving slightly to 8th in July and September. This indicates a stable consumer base and a reliable product line that resonates with customers in this category. Despite the slight fluctuations in monthly sales figures, Canna Clinicals has managed to retain its competitive position, suggesting effective brand loyalty or marketing strategies that keep them relevant in a highly competitive market.
Interestingly, the data reveals that Canna Clinicals did not appear in the top 30 brands in any other state or category, which may suggest a region-specific focus or a strategic decision to concentrate resources and marketing efforts in New York. This could be viewed as a missed opportunity for expansion or a calculated move to dominate a specific niche. The absence from other markets might also indicate potential for growth if the brand chooses to broaden its geographical reach or diversify its product offerings in the future.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Canna Clinicals has shown a steady performance, maintaining its position within the top 10 brands from June to September 2025. Notably, Canna Clinicals improved its rank from 9th in June to 8th in July, although it dipped back to 9th in August before climbing again to 8th in September. This fluctuation indicates a competitive market environment. In comparison, OMO - Open Minded Organics consistently held a higher rank, peaking at 5th in September, suggesting stronger sales momentum. Meanwhile, High Falls Canna New York maintained a stable 7th position throughout the period, indicating a consistent market presence. Jumbodose experienced a decline, dropping to 10th place by September, which may present an opportunity for Canna Clinicals to capture more market share. The absence of Ithaca Organics Cannabis Co. from the top 20 in the earlier months and its entry at 9th in September highlights the dynamic nature of this category. Overall, Canna Clinicals' ability to maintain and slightly improve its rank amidst these shifts suggests a resilient brand strategy in a competitive New York market.
Notable Products
In September 2025, Canna Clinicals' top-performing product was the CBD/THC 1:10 Max Strength Tincture (100mg CBD, 1000mg THC, 30ml) which maintained its first-place ranking for the fourth consecutive month, with sales reaching 385 units. The CBD/THC Unwind Tincture (1050mg CBD, 90mg THC, 15ml) also held steady in second place, showing consistent performance across the months. Max Strength Capsules 10-Pack (100mg CBD, 100mg THC) remained in third place, although its sales saw a notable increase compared to the previous month. The CBD/CBN/THC Sleep Tincture (300mg CBD, 300mg CBN, 150mg THC) held its position at fourth, while the CBD/THC Balance Tincture (100mg CBD, 500mg THC) slipped from fourth to fifth place. Overall, the rankings for these top products have shown remarkable stability, with only minor shifts in sales figures.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
